The Stephen Review

National Blood Agreement & National Blood Authority Act 2003

National Blood Authority Board

Jurisdictional Blood Committee

Schedule 4 Process

Barcoding in the Blood Sector

The Stewardship Statement


Schedule 4 Process

Under the National Blood Agreement, interested parties can make proposals for changes to products or services on the National Products and Supply List. Schedule 4 of the National Blood Agreement provides for evidence-based evaluation, information and advice to be provided to support decisions on these changes.

In 2006-07, the JBC determined that a suitable health economic evaluator should be procured to design a purpose-built methodology and framework to evaluate national blood supply change proposals and to apply the methodology and framework to the evaluation of all applications the NBA receives. An initial procurement process in December 2006 was unsuccessful in identifying an organisation to develop this methodology. As a result, the NBA separated the required work into two discrete sections and is currently investigating options for progressing it. It is expected that the evaluation framework will be developed and the first proposal presented for decision in 2007-08.

Related Documents

 

 

 

Feedback | Privacy | Copyright | Disclaimer | Contact Us

This page last modified on April 12, 2010
ABN 87 361 602 478 © Commonwealth of Australia 2010

BloodNet


Criteria for the Clinical Use of Intravenous Immunoglobulin (IVIg)


RFT 01/2012 - Review of the authorisation and clinical governance framework for intravenous immunoglobulin


AHMC Stewardship Statement


Patient Blood Management


Blood Supply to Australians Oversea


New supply arrangements for IVIg


Donate Blood